Brigitte Bernard-Chabert

Brigitte Bernard-Chabert

Auto-generated profile, based on publicly available information

Brigitte Bernard-Chabert

Hôpital Robert Debré, Service d'Hépatologie, Reims

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Hepatology
Verified
Journal Article
Closed access
EAEtienne Audureau
Etienne Audureau
FCFabrice Carrat
Fabrice Carrat
RLRichard Layese
Richard Layese
CCCarole Cagnot
Carole Cagnot
TATarik Asselah
Tarik Asselah
PNPierre Nahon
Pierre Nahon

30 June 2020 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
YMYasmina Ben Merabet
Yasmina Ben Merabet
CBcoralie barbe
coralie barbe
AHAlexandra Heurgue-Berlot
Alexandra Heurgue-Berlot
TTThierry Thévenot
Thierry Thévenot
AMAnne Minello
Anne Minello
Gérard ThiéfinGérard Thiéfin
Gérard Thiéfin
Background In patients with autoimmune hepatitis (AIH), relapse rates between 25 and 100% after treatment withdrawal have been reported. The optimal strategy for immunosuppressive treatment withdrawal is controversial. Aim To identify the predictive factors of histological remission and to assess the relapse rate after treatment withdrawal in AIH patients with prolonged biochemical response. Methods Patients with AIH and sustained biochemical remission on first-line treatment were retrospectively included. Histological response was defined as complete regression of interface hepatitis and lobular necrosis and no or minimal portal inflammation and relapse as any elevation of serum aminotransferase or gammaglobulin/IgG levels. Results Sixty-two patients were included. Forty-seven had a biopsy after a median biochemical response of 49.7 months. Twenty-five of them were histological responders. Independent predictors of histological remission were older age (OR = 1.1; CI 95%: 1.0; 1.2), mild-to-moderate fibrosis at diagnosis (OR = 8; CI: 1.4; 47.6) and aspartate aminotransferases < 0.6 × ULN (OR = 7.1; CI: 1.3; 36.7). Thirty-nine patients stopped therapy after a median biochemical response of 48.6 months. Twenty-four of them had a biopsy before treatment withdrawal: 21 were histological responders. The cumulative rate of relapse was 25% at 64 months. Conclusions This study indicates that older age, mild-to-moderate fibrosis at diagnosis and serum aspartate aminotransferases in the lower range of normal are independent predictors of histological response in AIH with prolonged biochemical response. The relapse rate after treatment withdrawal may be limited to 25% at 64 months when patients are selected on the basis of prolonged biochemical remission and, when available, histological response.

19 December 2018 in Santé Publique
Verified
Journal Article
Open access
PDF file
FBFabien Barrault
Fabien Barrault
MDMoustapha Dramé
Moustapha Dramé
AHAlexandra Heurgue
Alexandra Heurgue
TPTullio Piardi
Tullio Piardi
BBBrigitte Bernard-Chabert
Brigitte Bernard-Chabert
Gérard ThiéfinGérard Thiéfin
Gérard Thiéfin
Objective: To determine if the density of general practitioners (GPs) had an impact on overall survival of patients with hepatocellular carcinoma (HCC) and stage of HCC at initial diagnosis in a North-Eastern region of France. Methods: This retrospective study was performed with 246 consecutive HCC patients referred to a multidisciplinary meeting dedicated to hepatobiliary tumors in the Reims University Hospital from 2012 to 2016. The following data were collected: clinico-biological and radiological data, GP density in patient residence area, stage of HCC at diagnosis, treatment. Survival curves were calculated by Kaplan-Meier method and compared with log-rank test. Results: Fifty-one patients (20.7%) were living in a low GP density area (2.2 to 6.8 GPs/10000 inhabitants) and 195 (79.3%) in a high GP density area (6.8 à 12.6 GPs/10000 inhabitants). Overall survival of patients living in a low GP density area was not statistically different from that of patients living in a high GP density area (median survival of 11.7 and 14.8 months respectively; p = 0.58). The tumor stage at initial diagnosis and the delay between diagnosis and case presentation at the multidisciplinary meeting were not significantly different between high and low GP density areas. Conclusion: In a cohort of patients with HCC referred to a regional multidisciplinary meeting dedicated to hepatobiliary cancers, the GP density in residence area of patients with HCC did not influence significantly their survival nor the stage of HCC at diagnosis.

1 February 2019 in Revue D'Épidémiologie Et de Santé Publique
Verified
Journal Article
Closed access
LGL. Granconato
L. Granconato
JBJ.-P. Pais de Barros
J.-P. Pais de Barros
TMThomas Mouillot
Thomas Mouillot
LLL. Lagrost
L. Lagrost
BBB. Bernard-Chabert
B. Bernard-Chabert
DVD. Vuitton
D. Vuitton